BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36273268)

  • 21. Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth.
    Pizzi M; Piazza F; Agostinelli C; Fuligni F; Benvenuti P; Mandato E; Casellato A; Rugge M; Semenzato G; Pileri SA
    Oncotarget; 2015 Mar; 6(9):6544-52. PubMed ID: 25788269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo.
    Richter A; Sender S; Lenz A; Schwarz R; Hinz B; Knuebel G; Sekora A; Murua Escobar H; Junghanss C; Roolf C
    BMC Cancer; 2020 Mar; 20(1):184. PubMed ID: 32131762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer.
    Kim HM; Jeong I; Kim HJ; Kang SK; Kwon WS; Kim TS; Park KH; Jung M; Soong J; Lin SC; Chung HC; Rha SY
    Anticancer Res; 2018 Nov; 38(11):6171-6180. PubMed ID: 30396934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autophagosome-mediated EGFR down-regulation induced by the CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with resistance by T790M.
    So KS; Kim CH; Rho JK; Kim SY; Choi YJ; Song JS; Kim WS; Choi CM; Chun YJ; Lee JC
    PLoS One; 2014; 9(12):e114000. PubMed ID: 25486409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy.
    Siddiqui-Jain A; Drygin D; Streiner N; Chua P; Pierre F; O'Brien SE; Bliesath J; Omori M; Huser N; Ho C; Proffitt C; Schwaebe MK; Ryckman DM; Rice WG; Anderes K
    Cancer Res; 2010 Dec; 70(24):10288-98. PubMed ID: 21159648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of TMEM16A by CK2 and Its Role in Cellular Proliferation.
    Pinto MC; Schreiber R; Lerias J; Ousingsawat J; Duarte A; Amaral M; Kunzelmann K
    Cells; 2020 May; 9(5):. PubMed ID: 32380794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer.
    Pierre F; Chua PC; O'Brien SE; Siddiqui-Jain A; Bourbon P; Haddach M; Michaux J; Nagasawa J; Schwaebe MK; Stefan E; Vialettes A; Whitten JP; Chen TK; Darjania L; Stansfield R; Bliesath J; Drygin D; Ho C; Omori M; Proffitt C; Streiner N; Rice WG; Ryckman DM; Anderes K
    Mol Cell Biochem; 2011 Oct; 356(1-2):37-43. PubMed ID: 21755459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
    Richter A; Roolf C; Hamed M; Gladbach YS; Sender S; Konkolefski C; Knübel G; Sekora A; Fuellen G; Vollmar B; Murua Escobar H; Junghanss C
    BMC Cancer; 2019 Mar; 19(1):202. PubMed ID: 30841886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 4,5,7-Trisubstituted indeno[1,2-b]indole inhibits CK2 activity in tumor cells equivalent to CX-4945 and shows strong anti-migratory effects.
    Birus R; El-Awaad E; Ballentin L; Alchab F; Aichele D; Ettouati L; Götz C; Le Borgne M; Jose J
    FEBS Open Bio; 2022 Feb; 12(2):394-411. PubMed ID: 34873879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells.
    Olsen BB; Svenstrup TH; Guerra B
    Int J Oncol; 2012 Dec; 41(6):1967-76. PubMed ID: 23007634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Janus" efficacy of CX-5011: CK2 inhibition and methuosis induction by independent mechanisms.
    D'Amore C; Moro E; Borgo C; Itami K; Hirota T; Pinna LA; Salvi M
    Biochim Biophys Acta Mol Cell Res; 2020 Nov; 1867(11):118807. PubMed ID: 32745724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism.
    Lertsuwan J; Lertsuwan K; Sawasdichai A; Tasnawijitwong N; Lee KY; Kitchen P; Afford S; Gaston K; Jayaraman PS; Satayavivad J
    Cancers (Basel); 2018 Aug; 10(9):. PubMed ID: 30142881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Casein kinase 2 phosphorylates and induces the SALL2 tumor suppressor degradation in colon cancer cells.
    Hermosilla VE; Gyenis L; Rabalski AJ; Armijo ME; Sepúlveda P; Duprat F; Benítez-Riquelme D; Fuentes-Villalobos F; Quiroz A; Hepp MI; Farkas C; Mastel M; González-Chavarría I; Jackstadt R; Litchfield DW; Castro AF; Pincheira R
    Cell Death Dis; 2024 Mar; 15(3):223. PubMed ID: 38493149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of CK2 enhances UV-triggered apoptotic cell death in lung cancer cell lines.
    Zhao T; Jia H; Li L; Zhang G; Zhao M; Cheng Q; Zheng J; Li D
    Oncol Rep; 2013 Jul; 30(1):377-84. PubMed ID: 23595577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of casein kinase 2 prevents growth of human osteosarcoma.
    Takahashi K; Setoguchi T; Tsuru A; Saitoh Y; Nagano S; Ishidou Y; Maeda S; Furukawa T; Komiya S
    Oncol Rep; 2017 Feb; 37(2):1141-1147. PubMed ID: 27959425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library.
    Hung MS; Xu Z; Lin YC; Mao JH; Yang CT; Chang PJ; Jablons DM; You L
    BMC Cancer; 2009 May; 9():135. PubMed ID: 19419583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AKT/mTOR down-regulation by CX-4945, a CK2 inhibitor, promotes apoptosis in chemorefractory non-small cell lung cancer cells.
    So KS; Rho JK; Choi YJ; Kim SY; Choi CM; Chun YJ; Lee JC
    Anticancer Res; 2015 Mar; 35(3):1537-42. PubMed ID: 25750308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase CK2 impact on intracellular calcium homeostasis in prostate cancer.
    Afzal M; Kren BT; Naveed AK; Trembley JH; Ahmed K
    Mol Cell Biochem; 2020 Jul; 470(1-2):131-143. PubMed ID: 32436081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silmitasertib (CX-4945), a Clinically Used CK2-Kinase Inhibitor with Additional Effects on GSK3β and DYRK1A Kinases: A Structural Perspective.
    Grygier P; Pustelny K; Nowak J; Golik P; Popowicz GM; Plettenburg O; Dubin G; Menezes F; Czarna A
    J Med Chem; 2023 Mar; 66(6):4009-4024. PubMed ID: 36883902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.